Founder & Executive Chairperson at Biocon
Recombinant human insulin was imported by Western multinationals who sold it at one thousand rupees per vial. We used a recombinant DNA technology based on Pichia yeast to produce human insulin domestically, dropping the price to one hundred rupees and forcing competitors to match us.
This answer is part of a full interview with Kiran Mazumdar-Shaw, Founder & Executive Chairperson at Biocon.
Found this insight valuable? Share it with your network to help others learn from Kiran Mazumdar-Shaw's experience.
Use this answer in your research, article, or academic work
